The MMC formulation technology is a precisely engineered solution for developing amorphous formulations of small molecules and peptides. An MMC drug formulation mitigates development risk and shortens development time, making it an ideal solution for enabling novel drugs to reach their full potential and for improvement of existing drug products. With the recent advancement of the first product candidate into the clinical stage, the company is now entering the scale-up phase, further demonstrating the potential of MMC in real-world drug development.
Disruptive Pharma
Disruptive Pharma is an innovative clinical stage biotech and drug delivery company leveraging its mesoporous magnesium carbonate (MMC) technology to enable amorphous drug formulations.
